A carregar...

Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics

OBJECTIVE: To describe the clinical characteristics of Latin American patients with metastatic renal cell carcinoma (mRCC) who experienced a progression-free survival (PFS) for at least 15 months following treatment with sunitinib. PATIENTS AND METHODS: In this retrospective analysis, mRCC patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Smaletz, Oren, Chacón, Matias, de Oliveira Koch, Ludmila, de Carvalho Rocha, Daniela R, Cardoso, Fernanda C
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138036/
https://ncbi.nlm.nih.gov/pubmed/27942224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S111137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!